Resistance exercise but not aerobic exercise lowers remnant-like lipoprotein particle cholesterol in type 2 diabetes: A randomized controlled trial

Atherosclerosis

Volumn 213, Issue 2, 2010, Pages 552-557

  Gavin, Claire ^a   Sigal, Ronald J ^a,b,c   Cousins, Marion ^a   Menard, Michelle L ^a   Atkinson, Michelle ^a   Khandwala, Farah ^c   Kenny, Glen P ^a,b   Proctor, Spencer ^d   Ooi, Teik Chye ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Aerobic exercise; Diabetes mellitus; Remnant lipoproteins; Resistance exercise

Indexed keywords

APOLIPOPROTEIN B48; CHYLOMICRON REMNANT; LIPOPROTEIN; REMNANT LIKE LIPOPROTEIN PARTICLE CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING;

ADULT; AGED; APOLIPOPROTEIN B-48; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; RESISTANCE TRAINING; TRIGLYCERIDES;

EID: 78649751258     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.08.071     Document Type: Article

References (30)

1. Blair S.N., Kohl H.W., Paffenbarger R.S., et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989, 262:2395-2401.
2. Kannel W.B., McGee D.L. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979, 2:120-126.
3. Hu F.B., Stampfer M.J., Solomon C., et al. Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med 2001, 134:96-105.
4. Lee C.D., Blair S.N., Jackson A.S. Cardiorespiratory fitness, body composition and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr 1999, 69:373-380.
5. Ruiz J.R., Sui X., Lobelo F., et al. Association between muscular strength and mortality in men: prospective cohort study. BMJ 2008, 337:a439.
6. Snowling N.J., Hopkins W.G. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care 2006, 29:2518-2527.
7. Stamler J., Vaccaro O., Neaton J.D. Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16:434-444.
8. Fukushima H., Sugiyama S., Honda O., et al. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. J Am Coll Cardiol 2004, 43:2219-2224.
9. Karpe F., Boquist S., Tang R., et al. Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. J Lipid Res 2001, 42:17-21.
10. Kugiyama K., Doi H., Motoyama T., et al. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation 1998, 97:2519-2526.
11. Balducci S., Zanuso S. The Italian diabetes and exercise study (IDES): design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetes and the metabolic syndrome. Nutr Metab Cardiovasc Dis 2008, 18:585-595.
12. Sigal R.J., Kenny G.P., Boulé N.G., et al. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes. Ann Intern Med 2007, 147:357-369.
13. McNamara J.R., Shah P.K., Nakajima K., et al. Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study. Clin Chem 1998, 44:1224-1232.
14. Hardman A.E., Lawrence J.E.M., Herd S.L. Postprandial lipemia in endurance-trained people during a short interruption to training. J Appl Physiol 1998, 84:1895-1901.
15. Nakajima K., Okazaki M., Tanaka A., et al. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to Apo B-100 and Apo A-1. J Clin Lig Assay 1996, 19:177-183.
16. Ooi T.C., Cousins M., Ooi D.S., et al. Postprandial remnant-like lipoproteins in hypertriglyceridemia. J Clin Endocrinol Metab 2001, 86:3134-3142.
17. Kinoshita M., Kojima M., Matsushima T., Teramoto T. Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta 2005, 351:115-120.
18. Su J.W., Nzekwu M.M., Cabezas M.C., Redgrave T., Proctor S.D. Methods to assess impaired post-prandial metabolism and the impact for early detection of cardiovascular disease risk. Eur J Clin Invest 2009, 39:741-754.
19. Sacks F. Triglycerides are just a marker for specific atherogenic remnant lipoprotein particles. Atherosclerosis Suppl 2003, 4:9.
20. Stein D.T., Devaraj S., Balis D., Adams-Huet B., Jialal I. Effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2001, 21:2026-2031.
21. Ooi T.C., Cousins M., Ooi D.S., Nakajima K., Edwards A.L. Effect of fibrates on postprandial remnant-like particles in patients with combined hyperlipidemia. Atherosclerosis 2004, 172:375-382.
22. Kolovou G.D., Anagnostopoulou K.K., Daskalopoulou S.S., Mikhailidis D.P., Cokkinos D.V. Clinical relevance of postprandial lipaemia. Curr Med Chem 2005, 12:1931-1945.
23. Nakamura T., Kugiyama K. Triglycerides and remnant particles as risk factors for coronary artery disease. Curr Atheroscler Rep 2006, 8:107-110.
24. Doi H., Kugiyama K., Oka H., et al. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation 2000, 102:670-676.
25. Ai M., Tanaka A., Ogita K., et al. Relationship between hyperinsulinemia and remnant lipoprotein concentrations in patients with impaired glucose tolerance. J Clin Endocrinol Metab 2000, 85:3557-3560.
26. Gill J.M., Al-Mamari A., Ferrell W.R., et al. Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men. Atherosclerosis 2006, 185:87-96.
27. Gill J.M., Al-Mamari A., Ferrell W.R., et al. Effect of prior moderate exercise on postprandial metabolism in men with type 2 diabetes mellitus, heterogeneity of responses. Atherosclerosis 2007, 194:134-143.
28. Cohen J.C., Noakes T.D., Spinnler Benade A.J. Postprandial lipemia and chylomicron clearance in athletes and in sedentary men. Am J Clin Nutr 1998, 49:443-447.
29. Boyden T., Pamenter R. Resistance exercise training is associated with decreases in serum low-density lipoprotein cholesterol levels in pre-menopausal women. Arch Intern Med 1993, 153:97-100.
30. Thomas D., Elliott E.J., Naughton G.A. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 2006, 3:002968.